The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric Patients

This study has been completed.
Sponsor:
Collaborator:
ZonMw: The Netherlands Organisation for Health Research and Development
Information provided by:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT00402311
First received: November 20, 2006
Last updated: January 19, 2007
Last verified: November 2006
  Purpose

The purpose of this study is to determine the effects and cost-effectiveness of a Diagnostic Observation Center for PsychoGeriatric patients (DOC-PG). Our main hypothesis is that DOC-PG has added value compared with usual care regarding Health Related Quality of Life (HRQoL).


Condition Intervention
Delirium, Dementia, Amnestic, Cognitive Disorders
Memory Disorders
Procedure: DOC-PG: integrated multidisciplinary assessment
Procedure: Usual care: assessment by GP or one of the regional services

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: A Prospective Randomized Trial on the Effects of a Psychogeriatric Diagnostic Day Hospital

Resource links provided by NLM:


Further study details as provided by Maastricht University Medical Center:

Primary Outcome Measures:
  • The Visual Analogue Scale of the EuroQol-5D

Secondary Outcome Measures:
  • Utility score of the EuroQol-5D
  • Short Form 36 (SF-36)
  • Mini Mental State Examination (MMSE)
  • Global Deterioration Scale (GDS)
  • NeuroPsychiatric Inventory (NPI)
  • Instrumental Activities of Daily Living scale (IADL)
  • Cornell Scale of Depression in Dementia (CSDD)
  • Perceived Pressure from Informal Care (Dutch translation, EDIZ)
  • Informal care questionnaire

Estimated Enrollment: 216
Study Start Date: April 2002
Estimated Study Completion Date: August 2005
Detailed Description:

An integrated multidisciplinary approach to diagnosing and managing dementia is generally recommended, though rarely investigated. In recent years, multidisciplinary memory clinics (MCs) for patients with dementia have been established in many places over the world. These services have recently also been criticised for being principally hospital-based, for their apparently limited focus that entails only medical diagnostics and pharmacotherapy and for thus diverting resources from community mental health teams(CMHTs) .On the other hand, CMHTs are mainly concerned with the provision and organisation of integrated care, and unlike MCs, CMHTs generally have limited access to hospital-based diagnostics such as brain-imaging.

In April 2002, an outpatient diagnostic facility, the Diagnostic Observation Centre for PsychoGeriatric patients (DOC-PG) was established in Maastricht, the Netherlands. DOC-PG combines the hospital-based approach of the MC with the care-oriented approach of the regional CMHT and aims to provide the general practitioner (GP) with elaborate diagnostic and therapeutic advice for patients with cognitive disorders.

Comparison: DOC-PG is compared with usual care i.e. the GP took care of the diagnosis, or he or she referred the patient to one of the separate regional services, e.g. the Maastricht Memory Clinic (MMC), geriatric medicine, or the department of mental health for the elderly of the mental health community service (CMHT).

  Eligibility

Ages Eligible for Study:   55 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Aged 55 years or over
  • Suspected of having dementia or combined somatic/psychiatric disorder
  • No referral to other local/regional services in the last two years
  • Availability of a proxy (visiting the patient at least once a week)

Exclusion Criteria:

  • Acute disorders that need a prompt therapeutic intervention
  • Living in a nursing home or receiving care that is comparable to that of a nursing home
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00402311

Locations
Netherlands
Academic Hospital Maastricht
Maastricht, Limburg, Netherlands, 6202 AZ
Sponsors and Collaborators
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development
Investigators
Principal Investigator: Frans R Verhey, PhD, MD Maastricht University Medical Center
Study Director: Carmen D. Dirksen, PhD Maastricht University Medical Center
Study Director: Johan L Severens, PhD Maastricht University Medical Center
Study Chair: Alfons Kessels, MD, MSc Maastricht University Medical Center
Study Chair: Claire A Wolfs, MSc Maastricht University Medical Center
  More Information

Additional Information:
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00402311     History of Changes
Other Study ID Numbers: 945-02-055
Study First Received: November 20, 2006
Last Updated: January 19, 2007
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Maastricht University Medical Center:
Health Services for the Aged
Geriatric Psychiatry

Additional relevant MeSH terms:
Cognition Disorders
Delirium
Dementia
Memory Disorders
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Confusion
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Brain Diseases
Central Nervous System Diseases

ClinicalTrials.gov processed this record on July 23, 2014